FollowEcho Therapeutics (ECTE) shares were down more than 23% in early trading Friday after the company reported its Q1 net loss widened.
Echo’s net loss for Q1 2014 was $2.8 million compared to $7.0 million, or $1.30 per share, for Q1 2013. The operating loss for Q1 2014 was $2.7 million compared to $5.5 million for Q1 2013.
On a per share basis the loss was $0.23 per share compared with $1.30 per share.
Analyst estimates were not available.
ECTE trades in a 52-week range of $1.84 to $6.10.
The following two tabs change content below.
Kevin is a content-crafter at Wallstreet OTC specializing in editorial and news. He promised us that he will keep his articles short but he always seem to stop only when the character count maximum.
